Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9
Abstract
Share and Cite
Schulz, H.; Kuhn, C.; Hofmann, S.; Mayr, D.; Mahner, S.; Jeschke, U.; Schmoeckel, E. Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9. Int. J. Mol. Sci. 2018, 19, 323. https://doi.org/10.3390/ijms19010323
Schulz H, Kuhn C, Hofmann S, Mayr D, Mahner S, Jeschke U, Schmoeckel E. Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9. International Journal of Molecular Sciences. 2018; 19(1):323. https://doi.org/10.3390/ijms19010323
Chicago/Turabian StyleSchulz, Heiko, Christina Kuhn, Simone Hofmann, Doris Mayr, Sven Mahner, Udo Jeschke, and Elisa Schmoeckel. 2018. "Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9" International Journal of Molecular Sciences 19, no. 1: 323. https://doi.org/10.3390/ijms19010323
APA StyleSchulz, H., Kuhn, C., Hofmann, S., Mayr, D., Mahner, S., Jeschke, U., & Schmoeckel, E. (2018). Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9. International Journal of Molecular Sciences, 19(1), 323. https://doi.org/10.3390/ijms19010323

